The Analyst Landscape: 5 Takes On Omnicell
The Analyst Landscape: 5 Takes On Omnicell
分析師格局: 對omnicell的5個看法
Analysts' ratings for Omnicell (NASDAQ:OMCL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
過去一個季度，對Omnicell (納斯達克: OMCL) 的分析師評級從看好到看淡，由5位分析師提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $37.6, along with a high estimate of $44.00 and a low estimate of $30.00. Marking an increase of 25.33%, the current average surpasses the previous average price target of $30.00.
Omnicell Inc爲醫療保健提供自動化和商業分析軟件。它幫助客戶定義和提供成本效益的藥物管理，旨在使藥劑師和護士專注於患者護理而不是行政任務，並推動改善臨床、運營和財務結果，覆蓋所有護理環境。Omnicell絕大部分營業收入來自美國。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The perception of Omnicell by financial experts is analyzed through recent analyst...
營業收入下降：在3個月的...
登入免費觀看全文
登入/註冊